The FDA must crack down on dangerous knockoff weight-loss drugs
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in America. But just as these drugs are changing lives, a dangerous shadow market is growing alongside them.
